HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 41.30
-0.20 (-0.48%)
Sep 8, 2026, 1:30 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.15 billion as of September 8, 2026. Its market cap has decreased by -30.66% in one year.
Market Cap
2.15B
Enterprise Value
1.36B
Revenue
308.21M
Ranking
n/a
PE Ratio
16.38
Stock Price
41.30
ChartMarket Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.15B, a decrease of -48.22%. That is a compound annual growth rate of -19.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 2.15B | -25.70% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 2.75B |
| Energenesis Biomedical CO.,LTD. | 2.64B |
| GlycoNex Incorporation | 2.49B |
| 3D Global Biotech | 2.46B |
| Anti-Microbial Savior BioteQ | 2.28B |
| Syngen Biotech | 2.15B |
| Sunhawk Vision Biotech | 2.14B |
| Taiwan Bio Therapeutics | 2.10B |